• Address: Rm615, No.8 Building,Shengyu Industry Center
    No.365 Chuanhong road, Pudong, Shanghai

  • Call Us: (+86) 021-58211911
    [email protected]

Special Packaging Injection Molding Machine

Cefotaxime | C16H17N5O7S2 - PubChem

Cefotaxime is a third generation intravenous cephalosporin antibiotic. It has broad spectrum activity against Gram positive and Gram negative bacteria. It does not have activity against Pseudomonas aeruginosa. Cefotaxime works by inhibiting bacterial cell wall biosynthesis.

Cefotaxime acid European Pharmacopoeia (EP) Reference ...

Cefotaxime acid European Pharmacopoeia (EP) Reference Standard Synonym: Cefotaxime CAS Number 63527-52-6. Empirical Formula (Hill Notation) C 16 H 17 N 5 O 7 S 2. Molecular Weight 455.47 . EC Number 264-299-1. NACRES NA.24

Cefotaxime/Clavulanic acid | Microbiology | Antimicrobial ...

Buy and get information for Cefotaxime/Clavulanic acid, SD724, Microbiology, Antimicrobial Susceptibility, Sensitivty Discs, Antibacterial, As per CLSI & EUCAST

Cefotaxime acid manufacturer 63527-52-6 Purity 98% ...

Feb 23, 2019 · Cefotaxime acid manufacturer ,,/,cas No:63527-52-6,Formula:C16H17N5O7S2,purity:98%- Shanghai Yuanye Bio

Cefotaxime sodium | C16H16N5NaO7S2 - PubChem

Cefotaxime Sodium is the sodium salt form of cefotaxime, a beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Cefotaxime sodium binds to and inactivates penicillin -binding proteins (PBP) located on the inner membrane of the bacterial cell wall.

Amoxicillin-clavulanic acid versus cefotaxime in the ...

Amoxicillin-clavulanic acid is as effective as cefotaxime in the treatment of bacterial infections in cirrhotic patients, but is less expensive and can be administered orally. These results suggest that amoxicillin-clavulanic acid is an effective alternative to cefotaxime for the empirical treatment …

Cited by: 196

Cefotaxime Dosage Guide with Precautions - Drugs

Mar 12, 2021 · Detailed Cefotaxime dosage information for adults and children. Includes dosages for Urinary Tract Infection, Sinusitis, Skin or Soft Tissue Infection …

Estimated Reading Time: 7 mins

Cefotaxime + Clavulanic Acid #68456 | Clinical Diagnostics ...

1 cartridge of 50 disks of </nobr>30 μg</nobr> cefotaxime and </nobr>10 μg</nobr> clavulanic acid to test microbial susceptibility by diffusion on agar plates

Ceftazidime+Clavulanic Acid as a Better Method of ...

May 02, 2016 · Ceftazidime+Clavulanic Acid as a Better Method of Screening Extended Spectrum Beta Lactamases (ESBL) in the Family Enterobacteriaceae Int.J.Curr.Microbiol.App.Sci. 5(2): 267 -271 .

Extended Spectrum β-Lactamase (ESBL)-Producing ...

clavulanic acid or cefotaxime and cefotaxime/ clavulanic acid. Both strips have a decreasing gra-dient of ceftazidime or cefotaxime alone on one end and a decreasing gradient of ceftazidime or cefotaxime plus a fixed gradient of clavulanic acid on the other end. A >3log reduction in the MIC of cefotaxime or ceftazidime in the presence of

Amoxicillin-clavulanic acid versus cefotaxime in the ...

Background/Aim: Cefotaxime is considered the first-choice antibiotic for empirical treatment in cirrhotic patients developing bacterial infections. It has been suggested that amoxicillin-clavulanic acid could be an alternative to cefotaxime, particularly in patients developing bacterial infections while …

Cited by: 196

SYNTHESIS OF CEFOTAXIME FROM DAMA (DIETHYL …

Cefotaxime is a third-generation parenteral cephalosporin antibacterial used in the treatment of infections due to susceptible Gram-positive and Gram-negative bacteria, including infections of the abdomen, bones and joints, CNS, skin and skin structure, genito-urinary tract (including gonorrhoea) and respiratory tract, in gynaecological infections, and in early Lyme disease 2, 3.

Cefotaxime-non-susceptibility of Haemophilus influenzae ...

Cefotaxime-non-susceptible Haemophilus influenzae has rarely been isolated from clinical specimens. Although several reports have shown that amino acid (AA) alteration in penicillin-binding protein 3 (PBP3), encoded by the ftsI gene, reduces activity of cefotaxime, precise mechanisms conferring the non-susceptibility have been unclear.

Cited by: 6

Antibiotic susceptibility of Salmonella, Campylobacter ...

Oct 02, 2020 · Regarding drugs of last resort--cefotaxime, ciprofloxacin, and nalidixic acid--resistance was not common among Salmonella (6.3%). The resistance rate of Campylobacter spp. to last-resort drugs--erythromycin, ciprofloxacin, and nalidixic acid--varied between species. The observed trend was not statistically significant.

CLAFORAN Sterile (cefotaxime for injection, USP) and ...

Cefotaxime sodium is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Cefotaxime has activity in the presence of some beta-lactamases, both penicillinases and...

File Size: 317KB

cefotaximeù | Sigma-Aldrich

Cefotaxime acid. 1 Product Result | Match Criteria: Product Name Synonym ... Cefotaxime sodium salt Empirical Formula (Hill Notation): C 16 H 16 N 5 NaO 7 S 2. Molecular Weight: 477.45. CAS Number: 64485-93-4. C0685000 ; European Pharmacopoeia (EP) Reference Standard ...

BDBBL Sensi-Disc Antimicrobial Susceptibility Test Discs ...

BD BBL™ Sensi-Disc™ Antimicrobial Susceptibility Test Discs, Cefotaxime/Clavulanic Acid Used for semi-quantitative in vitro testing by agar disc diffusion test procedure of certain fastidious bacterial pathogens Specifications. Antimicrobial Agents: Cefotaxime/Clavulanic Acid: Concentration: 10μg ...

Antimicrobial Agents: Cefotaxime/Clavulanic Acid

Cefotaxime Combined Ellagic Acid in a Liposomal Form for ...

Oct 24, 2017 · Cefotaxime sodium and ellagic acid were purchased from Xian Warton Biological technology company (Shaanxi, China), α-phosphatidylcholine and cholesterol were purchased from Sigma-Aldrich (Detsenhofen, Germany), Tween 20 was purchased from Fluka (Düsseldorf, Germany), All other reagents and chemicals were of analytical grade. 2.1.

Cited by: 1

Oxoid Canada - Product Detail

Feb 01, 2003 · If the inhibition zone obtained meets at least one of the criteria shown above, then confirmatory testing is required using BOTH ceftazidime and cefotaxime with and without clavulanic acid i.e. CD02/CT0412B and CD03/CT0166B. The test is performed using Mueller-Hinton agar (Oxoid CM0337) and a 0.5 McFarland inoculum.

Claforan (cefotaxime) dosing, indications, interactions ...

2010 claforan-cefotaxime-342506 Drugs Drugs cefotaxime 2002 2002607-overview Diseases & Conditions

Evaluation of a new cefepime–clavulanate ESBL Etest to ...

Introduction

CEFOTAX%C4%B0ME | Sigma-Aldrich

Cefotaxime acid. 1 Product Result | Match Criteria: Product Name Synonym ... Cefotaxime sodium salt Empirical Formula (Hill Notation): C 16 H 16 N 5 NaO 7 S 2. Molecular Weight: 477.45. CAS Number: 64485-93-4. C0685000 ; European Pharmacopoeia (EP) Reference Standard ...

(PDF) Amoxicillin/clavulanic acid and cefotaxime ...

Amoxicillin / Clavulanic Acid and Cefotaxime Resistance in Salmonella Minnesota and Salmonella Heidelberg from Broiler Chickens Rodrigues IBBE 1 , Ferreira KFS 1 , Silva RL 1 , Ma chado SA 1 ...

Estimated Reading Time: 4 mins

Evaluation Of Thermo Scientific Sensititre Susceptibility ...

were manufactured to contain amoxicillin, amoxicillin/ clavulanic acid (constant 2), cefotaxime, meropenem and piperacillin-tazobactam. Enterobacteriaceae,spp., Acinetobacter spp. and Pseudomonas spp. were cultured onto Columbia Blood Agar and incubated at 36 ±1°C for 18-24 hr.

Evaluation of the MicroScan ESBL plus confirmation panel ...

Introduction

Product Name Cefotaxime sodium | Sigma-Aldrich

Search results for Cefotaxime sodium at Sigma-Aldrich. Changes will be taking place on SigmaAldrich on June 5, 2021 that include visual and functional updates.

(PDF) Comparative evaluation of efficacy and safety of ...

Patients received cefotaxime-sulbactam or amoxicillin-clavulanic acid injection intravenously for up to 7 days. There was no difference between the two groups in demography or disease ...

Claforan (cefotaxime) dosing, indications, interactions ...

2010 claforan-cefotaxime-342506 Drugs Drugs cefotaxime 2002 2002607-overview Diseases & Conditions

Cefotaxime (Injection Route) Side Effects - Mayo Clinic

Feb 01, 2021 · Don't delay your care at Mayo Clinic. Schedule your appointment now for safe in-person care. Learn more: Mayo Clinic facts about coronavirus disease 2019 (COVID-19) Our COVID-19 patient and visitor guidelines, plus trusted health information Latest on COVID-19 vaccination by site: Arizona patient vaccination updates Arizona, Florida patient vaccination updates Florida, Rochester patient ...

Cefotaxime / Cefotaxime + Clavulanic Acid (0.25 -16 / 0 ...

Cefotaxime / Cefotaxime + Clavulanic Acid (0.25 -16 / 0.016 -1) Cefotaxime / Cefotaxime + Clavulanic Acid (0.25 -16 / 0.016 -1) Catalogue number: 7576. Quantitative assay for determining the Minimum Inhibitory Concentration (MIC) Applications. General use Antibiotic susceptibility test. Industry.

Synthesis and effect of pegylation on citric acid ...

Dec 01, 2019 · Further, 200 mg of cefotaxime sodium (CFTX) is dissolved in 2 ml of Dimethyl sulfoxide (DMSO) and added to 1 ml of pegylated citric acid dendrimer under magnetic stirring maintained at 100 rpm for 24 h . Download : Download high-res image (78KB) Download : Download full-size image; Scheme 1. First-generation dendrimer

ETEST® for Antimicrobial Resistance Detection (ARD ...

Cefotaxime (0.25-16 μg/mL)/cefotaxime (0.016-1 μg/mL) + clavulanic acid (4 μg/mL constant concentration) 532208: 532200: ESBL TZ/TZL 32/4: Ceftazidime (0.5-32 μg/mL)/ceftazidime (0.064-4 μg/mL) + clavulanic acid (4 μg/mL constant concentration) 532508: 532500: ESBL PM/PML 16/4

EUCAST: SOPs and Guidance documents

Feb 23, 2016 · Guidance on cefotaxime and ceftazidime disks with and without clavulanic acid for ESBL confirmation (12 February, 2019) Guidance for industry on the working order between pharmaceutical industry, EMA and EUCAST (5 May, 2019)

Antibiotics Tested by NARMS | NARMS | CDC

Mar 15, 2018 · * N/A indicates that no MIC range of intermediate susceptibility exists † CLSI breakpoints are not established for streptomycin; interpretive standards used are NARMS-established breakpoints for resistance monitoring and should not be used to predict clinical efficacy. During 1999–2013 resistance was defined as ≥64 µg/mL; the breakpoint was updated to ≥32 µg/mL in 2014.

Abbreviations | The British Society for Antimicrobial ...

The cookie settings on this website are set to 'All Cookies' so that you have the best online experience possible from our site. If you wish to opt out click on the 'More Info' link.

Diverticular Disease: Antibiotics for Diverticulitis

Oct 05, 2013 · Cefotaxime (Claforan) plus metronidazole or clindamycin. Third-generation cephalosporins ensure Gram-negative coverage but don't cover anaerobes. Ampicillin and Sulbactam. Ampicillin and sulbactam (Unasyn) covers aerobic gram-negative rods, anaerobes and enterococci. Piperacillin and Tazobactam sodium

FDA Drug Shortages

Discontinuations Listed by Generic Name or Active Ingredient. Companies are required under Section 506C of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (as amended by the Food and Drug Administration Safety and Innovation Act) to notify FDA of a permanent discontinuance of certain drug products, six months in advance, or if that is not possible, as soon as practicable.

(PDF) Amoxicillin/Clavulanic Acid Versus Cefotaxime for ...

Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. By Jose Barrio. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. By Guadalupe Garcia-tsao.

Cephalexin (Oral Route) Side Effects - Mayo Clinic

Feb 01, 2021 · Acid or sour stomach anxiety belching burning feeling in the chest or stomach difficulty with moving dry mouth heartburn hyperventilation indigestion irregular heartbeats irritability itching of the vagina or genital area muscle pain or stiffness nervousness pain during sexual intercourse pain, swelling, or redness in the joints

Intravenous IV preparation and infusion guidelines - GlobalRPH

May 22, 2018 · Intravenous admixtures – preparation and infusion guidelines. This reference contains standard dilutions including IV admixture drug concentration, infusion volumes, and infusion rates.

Cefuroxime Axetil Oral: Uses, Side Effects, Interactions ...

Cefuroxime is used to treat a wide variety of bacterial infections.This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria.This antibiotic treats only ...

Diagnosis and Management of Acute Pyelonephritis in …

Mar 01, 2005 · Cefotaxime (Claforan) Every 8 to 12 hours — 1 to 2 g. Thrombophlebitis. Ceftriaxone (Rocephin) Once in 24 hours — 1 to 2 g. Leukopenia; elevated BUN and …

Renal Dosage Adjustment Guidelines for Antimicrobials

Cefotaxime Adult 1-2 g IV q8h (Therapeutic interchange to ceftriaxone in adults, see cephalosporin therapeutic interchange policy) - - - - - - - - - - - - - - - - - - - - - - Pediatric 25-100mg/kg IV q6-8h (100-200mg/kg/day) CrCl 10-50: same dose q12h CrCl <10: same dose q24h HD: Dose daily as CrCl <10. Give after dialysis on dialysis days.

Ampicillin-resistant non-beta-lactamase-producing ...

Apr 30, 2007 · Amino acid substitutions at positions 377, 385, and 389, which conferred cefotaxime and cefixime MICs 10 to 60 times higher than those of susceptible strains, were found for the first time in Europe. In 72 isolates for which the repressor acrR gene of the AcrAB efflux pump was sequenced, numerous amino acid substitutions were found.

CDSCO

Directorate General Of Health Services Ministry of Health & Family Welfare, Government of India

Side Effects of Ceftriaxone (Ceftriaxone Sodium and ...

Nov 04, 2020 · SIDE EFFECTS. Ceftriaxone is generally well tolerated. In clinical trials, the following adverse reactions, which were considered to be related to ceftriaxone therapy or of uncertain etiology, were observed:. LOCAL REACTIONS - pain, induration and tenderness was 1% overall. Phlebitis was reported in <1% after IV administration. The incidence of warmth, tightness or induration was 17% …

Clinical Practice Guidelines : Antimicrobial guidelines

Cefotaxime: 50 mg/kg (2 g) IV 12H (week 1 of life), 6-8H (week 2-4 of life), 6H (>week 4 of life) Ceftriaxone: usual 50 mg/kg (2 g) IV daily; severe (including meningitis and brain abscess) 100 mg/kg (2 g) IV daily or 50 mg/kg (1 g) IV 12H; Where possible, ceftriaxone should be avoided in neonates <41 ...

Rocephin (ceftriaxone) dosing, indications, interactions ...

Medscape - Indication-specific dosing for Rocephin (ceftriaxone), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information.

Suprax (Cefixime): Uses, Dosage, Side Effects ...

Oct 26, 2020 · Chemically, it is (6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo [4.2.0] oct-2-ene-2-carboxylic acid, 7 2-(Z)-[O-(carboxy methyl) oxime] trihydrate. Molecular weight = 507.50 as the trihydrate. Chemical Formula is C 16 H 15 N 5 O 7 S 2.3H 2 O. The structural formula for cefixime is:

Neonatal Drug Formulary (WoS) - Children and Young …

Search Children and Young People's Services MKN . Home; Communities of Practice; Guidelines and Policy; Resources; Members & Contact Us

Gentamicin | Interactions | BNF content published by NICE

Cefotaxime. Both gentamicin and cefotaxime can increase the risk of nephrotoxicity. Cefoxitin. Both gentamicin and cefoxitin can increase the risk of nephrotoxicity. ... Both gentamicin and mefenamic acid can increase the risk of nephrotoxicity. Meloxicam. Both gentamicin and meloxicam can increase the risk of nephrotoxicity.

CEFOTAXIME | Drug | BNFc content published by NICE

By intravenous injection, or by intravenous infusion. For Child 16–17 years. 1 g every 8 hours for 7 days, may be switched 24–48 hours after symptoms improve to a suitable oral antibacterial.

2016-2027 Global 7-Aminocephalosporanic Acid (7-ACA ...

Jun 06, 2021 · 7-Aminocephalosporanic Acid (7-ACA) market companies. Research organizations and consulting companies. Organizations, associations and alliances related to the 7-Aminocephalosporanic Acid …

US Patent Application for CONJUGATES AND METHODS OF …

In certain embodiments, the recognition element is a group of formula R 1-L-, where R 1 is a fatty acid acyl optionally substituted with N(R N) 2, methoxypolyethylene glycol acetic acid acyl, methoxypolyethylene glycol propionic acid acyl, an amino acid residue, a dipeptide, a tripeptide, β-N-acetylglucosamine, a β-1,4-glucan, an optionally ...

Search Results | DrugBank Online

Building a healthcare software solution? Take a short survey and support a cause you love. Take Survey

Submit Your Requirement Below For injection molding Proposal!